Skip to main content

Table 3 The efficacy evaluation for propofol and barbiturates in controlling refractory status epilepticus

From: Systematic review and meta-analysis of propofol versus barbiturates for controlling refractory status epilepticus

Author Efficacy determination Adverse reactions
DCR ACT (minutes) ATIPT (days) CFR Hypotension incidence
Propofol Barbiturates Propofol Barbiturates Propofol Barbiturates Propofol Barbiturates Propofol Barbiturates
n/N % n/N % n/N % n/N % n/N % n/N %
van Gestel JP [14] 14/22 64 11/20 55 2/22 9 8/20 40
Xiuquan F [12] 7/9 77.7 4/9 44.4 3.71 ± 1.1 116 ± 31 2 ± 0.08 6 ± 0.31 5/9 66.6 6/9 55.5 7/9 77.7 6/9 66.6
Zengming W [11] 6/7 85.7 6/7 85.7 5.62 ± 2.1 52 ± 17 3 ± 0.12 6 ± 0.27 1/7 14.3 1/7 14.4
Rossetti AO [15] 6/14 43 2/9 22 4 13.5 6/14 43 3/9 33 7/14 50 5/9 55
Xiang C [13] 8/9 88.8 8/9 88.8 5.58 ± 2.51 51.91 ± 2.49 3.01 ± 0.11 6.03 ± 0.19 1/9 11.1 1/9 11.1
Chunfen Z [17] 44/45 97.7 37/45 82.2 15.51 ± 1.41 24.39 ± 2.77 2.62 ± 1.21 3.61 ± 2.59
Linzhi C [16] 22/28 78.57 11/28 39.28 3.78 ± 1.1 52.6 ± 17.94 18/28 64.28 19/28 67.85 15/28 53.57 17/28 60.71
  1. DCR, disease control rate; ACT, Average control time; ATIPT, Average tracheal intubation placement time; CFR, case fatality rate